Markets:

Overview

News

Currencies

International

Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

174.60 -3.19 (-1.79%)

Streaming Delayed Price Updated: 3:14 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >

Expert Ratings for Belite Bio ↗

December 14, 2023

Via Benzinga

Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

November 30, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Participate in the BTIG Ophthalmology Day

November 20, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results

November 13, 2023

From Belite Bio, Inc

Via GlobeNewswire

Expert Ratings for Belite Bio ↗

August 10, 2023

Via Benzinga

The Latest Analyst Ratings for Belite Bio ↗

July 25, 2023

Via Benzinga

Analyst Expectations for Belite Bio's Future ↗

June 20, 2023

Via Benzinga

Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing

November 10, 2023

Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results

November 07, 2023

From Belite Bio, Inc

Via GlobeNewswire

Why Shares of Belite Bio Are Slumping Wednesday ↗

May 31, 2023

The biopharmaceutical company announced a stock sale that's not great news to current investors.

Via The Motley Fool

Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023

November 06, 2023

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event

From Virtual Investor Conferences

Via GlobeNewswire

Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting

November 06, 2023

From Belite Bio, Inc

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts

November 01, 2023

Virtual Investor Conference on November 8th and 9th, 2023

From Virtual Investor Conferences

Via GlobeNewswire

Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting

October 27, 2023

From Belite Bio, Inc

Via GlobeNewswire

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...

Via Benzinga

Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results

August 08, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results

August 04, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA

July 27, 2023

From Belite Bio, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗

July 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗

July 26, 2023

Via Benzinga

Belite Bio Completes Enrollment in Pivotal Global Phase 3 DRAGON Trial Evaluating Oral Tinlarebant for Stargardt Disease

July 24, 2023

From Belite Bio, Inc

Via GlobeNewswire

Why Shares of Belite Bio Soared This Week ↗

June 30, 2023

The clinical-stage biotech company bounced back from a 52-week low late last week.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 26, 2023

Via Benzinga

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday ↗

June 26, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 16, 2023

Friday's session saw 32 companies set new 52-week lows.

Via Benzinga

Top 5 Health Care Stocks That Are Set To Fly In Q2 ↗

June 09, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 31, 2023

Via Benzinga

Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 31, 2023

Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.